Mark A. Goldsmith - Aug 11, 2022 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Role
President and Chief Executive Officer, Director
Signature
/s/ Jack Anders, as attorney-in fact for Mark A. Goldsmith
Stock symbol
RVMD
Transactions as of
Aug 11, 2022
Transactions value $
$4,900
Form type
4
Date filed
8/15/2022, 04:56 PM
Previous filing
Aug 10, 2022
Next filing
Feb 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVMD Common Stock Options Exercise $4.9K +10K +5.08% $0.49* 207K Aug 11, 2022 Direct F4
holding RVMD Common Stock 37K Aug 11, 2022 Trust F1
holding RVMD Common Stock 37K Aug 11, 2022 Trust F2
holding RVMD Common Stock 267K Aug 11, 2022 Trust F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RVMD Stock Option (Right to Buy) Options Exercise $0 -10K -6.35% $0.00 147K Aug 11, 2022 Common Stock 10K $0.49 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Held by Jonathan Henry Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
F2 Held by Rebecca Eve Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
F3 Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.
F4 Includes 130,500 RSUs.

Remarks:

President and Chief Executive Officer